Cargando…
ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK/ERK signaling pathway
Pancreatic adenocarcinoma (PAAD) is one of the most aggressive digestive system tumors in the world, with a low early diagnosis rate and a high mortality. Integrin beta 5 (ITGB5) is demonstrated to be a potent tumor promoter in several carcinomas. However, it is unknown whether ITGB5 participates in...
Autores principales: | Wen, Xin, Chen, Si, Chen, Xueting, Qiu, Hui, Wang, Wei, Zhang, Nie, Liu, Wanming, Wang, Tingting, Ding, Xin, Zhang, Longzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563233/ https://www.ncbi.nlm.nih.gov/pubmed/36249018 http://dx.doi.org/10.3389/fonc.2022.887068 |
Ejemplares similares
-
Netrin-1 suppresses the MEK/ERK pathway and ITGB4 in pancreatic cancer
por: An, Xi-Zhou, et al.
Publicado: (2016) -
Extended adjuvant temozolomide in newly diagnosed glioblastoma: A single-center retrospective study
por: Chen, Jie, et al.
Publicado: (2022) -
Integrin beta 4 (ITGB4) and its tyrosine-1510 phosphorylation promote pancreatic tumorigenesis and regulate the MEK1-ERK1/2 signaling pathway
por: Meng, Xiangli, et al.
Publicado: (2020) -
Systematic pan‐cancer analysis identifies RBM39 as an immunological and prognostic biomarker
por: Zhang, Rui, et al.
Publicado: (2022) -
CircNEK6 promotes the progression of pancreatic ductal adenocarcinoma through targeting miR-503/CCND1 axis
por: Shao, Zhiying, et al.
Publicado: (2023)